再生医療を目指した間葉系幹細胞自動培養装置「ゆりかご」の開発
スポンサーリンク
概要
- 論文の詳細を見る
We accomplished the following three very important break-through 1) we established technology for Superproliferation of MSC and developed Automatic cell culture system, 2) we conducted pre-clinical tests in animal experiments designed for dental applications and 3) we participated and supported clinical research into actual treatment of periodontal disease.<BR>We developed Automatic Cell Culture system for mesencymal stem cells(MSC) 'YURIKAGO' in 2007. The system has various characteristics 1) size is smaller than other system, 2) weight is lighter than other systems, 3) culture program is all automatic (culture, passage and harvest) and 4) we can proliferate MSC for the vast numbers required for treatment with having kept retention of multilineage differentiation potential. The key to this system is original MSC proliferation technology obtained by TWO CELLS that utilize basic Fibroblast Growth Factor(bFGF) that takes a few MSC and produces the vast numbers required for treatment. It is a wish that an intractable disease can be treated using our system and MSC.
- 日本炎症・再生医学会の論文
日本炎症・再生医学会 | 論文
- 新規キノリノン誘導体TA-270の炎症性気道疾患に対する効果
- Salazosulphapyridine, Predonizolone の好中球機能に及ぼす影響と Sodium ferrous citrate との併用効果についての検討
- Sodium ferrous citrate の好中球機能に及ぼす影響
- Mesalazine(Pentasa) の好中球機能に及ぼす影響と Sodium ferrous citrate(SFC) との併用効果についての検討
- 非ウイルスベクターによる細胞標的法の開発